Page 16 - Lockton Total Rewards Practice
P. 16
Optimize
Actionable cost containment opportunities
SPECIALTY ORGAN AND
PHARMACY TISSUE IMPLANTS
Clinical strategies
Diagnosis conirmation
Treatment alternatives
ACTIONABLE Provider optimization
OPPORTUNITIES Pricing negotiation HIGH RISK
DEFINED ONCOLOGY PREGNANCY AND
Predetermined set of medical Treatment protocol
diagnostic categories where Rx cost containment NEONATAL
known impact can be made
Claim audit and re-pricing
Plan design recommendations
Site of care review
Domestic steerage
ESRD/DIALYSIS HEMOPHILIA
Overview — Lockton Total Rewards Practice 16 Lockton Companies
Actionable cost containment opportunities
SPECIALTY ORGAN AND
PHARMACY TISSUE IMPLANTS
Clinical strategies
Diagnosis conirmation
Treatment alternatives
ACTIONABLE Provider optimization
OPPORTUNITIES Pricing negotiation HIGH RISK
DEFINED ONCOLOGY PREGNANCY AND
Predetermined set of medical Treatment protocol
diagnostic categories where Rx cost containment NEONATAL
known impact can be made
Claim audit and re-pricing
Plan design recommendations
Site of care review
Domestic steerage
ESRD/DIALYSIS HEMOPHILIA
Overview — Lockton Total Rewards Practice 16 Lockton Companies